Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 14;173(7):1705-1715.e16.
doi: 10.1016/j.cell.2018.05.046.

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

Collaborators

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Electronic address: douglas.ruderfer@vanderbilt.edu et al. Cell. .

Abstract

Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology. Understanding the genetic factors contributing to the shared and disorder-specific symptoms will be crucial for improving diagnosis and treatment. In genetic data consisting of 53,555 cases (20,129 bipolar disorder [BD], 33,426 schizophrenia [SCZ]) and 54,065 controls, we identified 114 genome-wide significant loci implicating synaptic and neuronal pathways shared between disorders. Comparing SCZ to BD (23,585 SCZ, 15,270 BD) identified four genomic regions including one with disorder-independent causal variants and potassium ion response genes as contributing to differences in biology between the disorders. Polygenic risk score (PRS) analyses identified several significant correlations within case-only phenotypes including SCZ PRS with psychotic features and age of onset in BD. For the first time, we discover specific loci that distinguish between BD and SCZ and identify polygenic components underlying multiple symptom dimensions. These results point to the utility of genetics to inform symptomology and potential treatment.

Keywords: bipolar disorder; polygenic risk; psychosis; schizophrenia; subphenotypes.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests

The authors declare no competing interests.

Figures

Figure 1.
Figure 1.. Associated Genomic Loci Shared and Divergent Between BD and SCZ
a) Odds ratios (OR) from independent data sets of BD (blue) and SCZ (red) for each of the 114 genome-wide significant variants in the BD and SCZ vs controls GWAS. b) Manhattan plot for SCZ vs BD GWAS.
Figure 2.
Figure 2.. Polygenic Risk Score Dissection of Clinical Symptom Dimensions
Effect size (calculated by dividing regression estimate by standard error) from regression analysis including ancestry covariates for each subphenotype and PRS for BD (x-axis) and SCZ (y-axis). Point size represents −log10(p-value) with SCZ (red) and BD (blue). Numbered subphenotypes are 1) comorbid migraine, 2) panic attacks 3) suicide attempt 4) mixed states 5) rapid cycling 6) comorbid eating disorder 7) comorbid OCD 8) year of birth 9) suicide ideation 10) panic disorder 11) number of suicide attempts 12) depressive symptoms (SCZ) 13) episodes depressive 14) episodes total 15) positive symptoms (SCZ) 16) irritable mania 17) age of onset depression 18) family history 19) episodes mixed mania 20) unipolar mania 21) alcohol substance dependence 22) age of onset mania 23) age at interview 24) number of hospitalizations. All subphenotypes are in BD except those labeled (SCZ).

References

    1. Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu Y-H, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry J-M, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen H-C, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Zompo MD, DePaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn J-P, Kassem L, Kuo P-H, Kato T, Kelsoe J, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O’Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Volkert J, Witt S, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Baune BT, 2018. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatry 75, 65–74. 10.1001/jamapsychiatry.2017.3433 - DOI - PMC - PubMed
    1. Balaraman Y, Lahiri DK, Nurnberger JI, 2015. Variants in Ion Channel Genes Link Phenotypic Features of Bipolar Illness to Specific Neurobiological Process Domains. Mol. Neuropsychiatry 1, 23–35. 10.1159/000371886 - DOI - PMC - PubMed
    1. Bayés À, van de Lagemaat LN, Collins MO, Croning MDR, Whittle IR, Choudhary JS, Grant SGN, 2011. Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat. Neurosci 14, 19–21. 10.1038/nn.2719 - DOI - PMC - PubMed
    1. Benner C, Spencer CCA, Havulinna AS, Salomaa V, Ripatti S, Pirinen M, 2016. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501. 10.1093/bioinformatics/btw018 - DOI - PMC - PubMed
    1. Bera TK, Bera J, Brinkmann U, Tessarollo L, Pastan I, 2001. Cse1l Is Essential for Early Embryonic Growth and Development. Mol. Cell. Biol 21, 7020–7024. 10.1128/MCB.21.20.7020-7024.2001 - DOI - PMC - PubMed

Publication types